SKI Market

A+| A| A-|

Indian Indices

Sensex

76,034.42 -829.29
( -1.08%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

54,230.47 -794.90
(-1.44%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

43.23

64130.13

EPS(TTM)

Face Value()

Div & Yield %

52.57

0.11

Back

viram suvarn ltd

Radhe Developers (India) reports standalone net loss of Rs 1.53 crore in the December 2025 quarter

Jan 30,2026

Net Loss of Radhe Developers (India) reported to Rs 1.53 crore in the quarter ended December 2025 as against net loss of Rs 1.38 crore during the previous quarter ended December 2024. Sales reported to Rs 0.08 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.08	0	0
OPM %	-1375.00	0	-
PBDT	-1.29	-1.11	-16
PBT	-1.54	-1.29	-19
NP	-1.53	-1.38	-11

76,034.42 -829.29 ( -1.08%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

54,230.47 -794.90 (-1.44%)

10,300.41 -53.36 (-0.52%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)